Sweet Syndrome Following SARS-CoV2 Vaccination.

Sweet’s syndrome adverse event mRNA vaccines neutrophilic dermatoses

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
20 Oct 2021
Historique:
received: 26 09 2021
revised: 16 10 2021
accepted: 16 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 28 11 2021
Statut: epublish

Résumé

Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-year-old Caucasian male who presented with an acute febrile eruption that arose 72 h after the first dose of the BNT162b2 vaccine. The clinicopathological findings were consistent with Sweet's syndrome. The short latency time suggested a possible role of the vaccine in triggering Sweet's syndrome in this case.

Identifiants

pubmed: 34835143
pii: vaccines9111212
doi: 10.3390/vaccines9111212
pmc: PMC8622799
pii:
doi:

Types de publication

Case Reports

Langues

eng

Références

J Cutan Pathol. 2021 Jul 22;:
pubmed: 34292611
Clin Exp Immunol. 2014 Oct;178(1):48-56
pubmed: 24903614
Br J Surg. 1990 Jul;77(7):809-10
pubmed: 2383758
Clin Exp Immunol. 2017 Sep;189(3):383-391
pubmed: 28518224
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e534-e535
pubmed: 32452542
J Med Virol. 2021 Oct;93(10):5718-5720
pubmed: 34214206
Front Immunol. 2019 Mar 12;10:414
pubmed: 30930894
Nat Rev Immunol. 2021 Apr;21(4):195-197
pubmed: 33674759
Acta Derm Venereol. 2002;82(3):221
pubmed: 12353722
Vaccines (Basel). 2021 Apr 29;9(5):
pubmed: 33946748
Allergy. 2021 Oct;76(10):3194-3196
pubmed: 34143448
J Am Acad Dermatol. 2005 Feb;52(2):367-9
pubmed: 15692491
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Acta Derm Venereol. 2021 Jun 30;101(6):adv00486
pubmed: 34159397
Cutan Ocul Toxicol. 2013 Sep;32(3):260-1
pubmed: 23351017
J Am Acad Dermatol. 2013 Oct;69(4):557-64
pubmed: 23891394
J Am Acad Dermatol. 2021 Jul;85(1):46-55
pubmed: 33838206
Acta Derm Venereol. 1986;66(4):357-8
pubmed: 2430413
Am J Dermatopathol. 2007 Apr;29(2):125-33
pubmed: 17414432
BMJ Case Rep. 2021 Jul 26;14(7):
pubmed: 34312136

Auteurs

Maria Efenesia Baffa (ME)

Department of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.

Roberto Maglie (R)

Department of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.

Neri Giovannozzi (N)

Department of Health Sciences, Section of Pathological Anatomy, University of Florence, 50139 Florence, Italy.

Francesca Montefusco (F)

Department of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.

Stefano Senatore (S)

Department of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.

Daniela Massi (D)

Department of Health Sciences, Section of Pathological Anatomy, University of Florence, 50139 Florence, Italy.

Emiliano Antiga (E)

Department of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.

Classifications MeSH